FROM STEPHEN 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Apr 9, 2021
Insider Transaction Report
Form 4
FROM STEPHEN
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2021-04-08$4.94/sh−899$4,441→ 71,949 total
Footnotes (2)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 04/01/2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.94, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.